Chi‐Hung Tzang

855 citations
13 papers · 718 indexed · h-index 11
Topics
Liver physiology and pathology (2 papers)Liver Disease Diagnosis and Treatment (2 papers)Advanced biosensing and bioanalysis techniques (2 papers)

In The Last Decade

Chi‐Hung Tzang

13 papers receiving 712 citations

Peers

Chi‐Hung Tzang
Comparison fields: 5 of 86
  • Molecular Biology 359
  • Epidemiology 159
  • Hepatology 152
  • Cancer Research 131
  • Oncology 129
Replace Leiming Xu with:
Leiming Xu China
Sayed S. Daoud United States
Tomonori Matsumoto Japan
Xiaoyuan Zi China
Huiwei Sun China
Benjamin J. Dwyer United Kingdom
Kjetil Elvevold Norway
Kuan Hu China
Praveen Radhakrishnan Germany
Chi‐Hung Tzang relative to Leiming Xu China Leiming Xu's profile →
Citations per field
00.5×1.5×
Leiming Xu · 1×
Citations per year

Countries citing papers authored by Chi‐Hung Tzang

Since Specialization
Citations

This map shows the geographic impact of Chi‐Hung Tzang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Hung Tzang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Hung Tzang more than expected).

Fields of papers citing papers by Chi‐Hung Tzang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Hung Tzang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Hung Tzang. The network helps show where Chi‐Hung Tzang may publish in the future.

Co-authorship network of co-authors of Chi‐Hung Tzang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Hung Tzang. A scholar is included among the top collaborators of Chi‐Hung Tzang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Hung Tzang. Chi‐Hung Tzang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 27
2 14
3 132
4 22
5 14
6 8
7 36
8 70
9 54
10 38
11
Differential gene expression profiles in paclitaxel-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells.
7
12 103
13 193

About Chi‐Hung Tzang

Chi‐Hung Tzang is a scholar working on Hepatology, Cancer Research and Biochemistry, having authored 13 papers that have together received 718 indexed citations. Recurring topics across this work include Liver physiology and pathology (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Hepatology (152 citations), Cancer Research (131 citations) and Molecular Biology (359 citations). Chi‐Hung Tzang has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Mengsu Yang, Minghui Huang, Chi‐Chun Fong, Xin‐Yuan Guan, Liang Hu, Sze Hang Lau, Meng‐Chao Wu, Dan Xie, Wenfang Chen and Man‐Sau Wong. Their work appears in journals such as Oncogene, Clinical Cancer Research and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026